9 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
in the event of a restatement, applies to incentive compensation beginning in Fiscal Year 2023. SHAREHOLDER ENGAGEMENT Takeda is committed to regular
6-K
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:20am
for all subsequent periods.
SHAREHOLDER ENGAGEMENT
Takeda is committed to regular, ongoing engagement with shareholders to make sure that we continue
6-K
TAK
Takeda Pharmaceutical Co
31 May 22
Current report (foreign)
6:18am
to apply for all subsequent periods.
SHAREHOLDER ENGAGEMENT
Takeda is committed to regular, ongoing engagement with shareholders to make sure that we
6-K
TAK
Takeda Pharmaceutical Co
6 Aug 21
Current report (foreign)
6:10am
SHAREHOLDER ENGAGEMENT
Takeda is committed to regular, ongoing engagement with shareholders to make sure that we continue to understand shareholder feedback
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 Jun 21
Current report (foreign)
7:38am
provides guidance to the Board. SHAREHOLDER ENGAGEMENT Takeda is committed to regular, ongoing engagement with shareholders to make sure that we continue
6-K
EX-99.1
ed238 k42q
21 Jun 21
Current report (foreign)
6:05am
6-K
EX-99.1
9ugq hki7ad63f
28 May 21
Current report (foreign)
6:07am
6-K
EX-99.1
8av32
17 Dec 20
Current report (foreign)
6:01am
6-K
5uww4
27 May 20
Current report (foreign)
6:13am
- Prev
- 1
- Next